Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Youths and Adults
NCT03654677Phase 3Completed
- Sponsor
- Boryung
- Start
- Sep 2017
- Primary completion
- Oct 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis A vaccine inactivated in hepatitis A (HAV), sponsored by Boryung. Started Sep 2017; status: completed.
02
Drugs
hepatitis A vaccine inactivated
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT03654677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03654677.